Immutep Ltd
ASX:IMM
Immutep Ltd
Cash from Financing Activities
Immutep Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immutep Ltd
ASX:IMM
|
Cash from Financing Activities
AU$76m
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Financing Activities
$67.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-8%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Financing Activities
-AU$2.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Financing Activities
AU$10.2m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Cash from Financing Activities
AU$28.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
27%
|
CAGR 10-Years
22%
|
See Also
What is Immutep Ltd's Cash from Financing Activities?
Cash from Financing Activities
76m
AUD
Based on the financial report for Dec 31, 2023, Immutep Ltd's Cash from Financing Activities amounts to 76m AUD.
What is Immutep Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
19%
The average annual Cash from Financing Activities growth rates for Immutep Ltd have been 15% over the past three years , 29% over the past five years , and 19% over the past ten years .